Patents by Inventor Shanhong Wan

Shanhong Wan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12085039
    Abstract: Provided are a composite coating, a piston, an engine, and a vehicle. The composite coating comprises a metal bonding layer, a transition layer, a ceramic layer, and a sealing layer which are sequentially laminated, wherein the metal bonding layer is configured to be bonded with a piston basic body, the metal bonding layer is a rare earth metal modified bonding layer, and the transition layer is a rare earth metal modified zirconia layer.
    Type: Grant
    Filed: March 30, 2022
    Date of Patent: September 10, 2024
    Assignee: WEICHAI POWER CO., LTD.
    Inventors: Fei Ma, Ninglu Wang, Lingyan Guo, Shanhong Wan, Guolong Huang, Qiangzhen Zang
  • Publication number: 20240026837
    Abstract: Provided are a composite coating, a piston, an engine, and a vehicle. The composite coating comprises a metal bonding layer, a transition layer, a ceramic layer, and a sealing layer which are sequentially laminated, wherein the metal bonding layer is configured to be bonded with a piston basic body, the metal bonding layer is a rare earth metal modified bonding layer, and the transition layer is a rare earth metal modified zirconia layer.
    Type: Application
    Filed: March 30, 2022
    Publication date: January 25, 2024
    Inventors: Fei MA, Ninglu WANG, Lingyan GUO, Shanhong WAN, Guolong HUANG, Qiangzhen ZANG
  • Publication number: 20120207771
    Abstract: The present invention provides methods and kits for assessing whether a subject is afflicted with an FR?-expressing cancer, methods and kits for predicting the progression of ovarian cancer in a subject afflicted with an FR?-expressing cancer, methods and kits for assessing the level of risk that a subject will develop an FR?-expressing cancer, and methods of stratifying a subject with an FR?-expressing cancer into cancer therapy groups. The methods involve determining the level of folate receptor alpha (FR?) which is not bound to a cell in a sample derived from the subject and comparing this level with the level of FR? in a control sample.
    Type: Application
    Filed: November 4, 2011
    Publication date: August 16, 2012
    Applicant: Morphotek Inc.
    Inventors: Daniel J. O'Shannessy, Luigi Grasso, Shanhong Wan, Qimin Chao, Elizabeth Brooke Somers